Pharmgate acquires chlortetracycline product licenses in Latin America.

August 08, 2013 -- Pharmgate LLC of Ramsey, New Jersey is pleased to announce the acquisition of a number of chlortetracycline product registrations in Latin America. As the majority owned US subsidiary of Jinhe Biotechnology, the largest manufacturer of chlortetracycline in the world, Pharmgate will become a significant supplier of its branded chlortetracycline products in the Latin American market.

At the same time, Pharmgate is pleased to announce the appointment of Alfonso Rueda as Business Manager, Latin America to manage its growing business in these markets. Mr. Rueda, based in Colombia, has a strong background in the Latin American animal nutrition and health industry with companies such as American Cyanamid, Roche, DSM and Provimi.

Pharmgate will continue to market the products through the existing distributor network utilizing both commercial and technical synergies.

Colin Gray, CEO of Pharmgate commented, “These important registrations give us the ability to further implement our forward integration strategy in providing quality products directly to the market. In optimizing our manufacturing to customer supply chain we control quality while bringing consistency, reliability and value to these markets. These acquisitions are further evidence of the successful Pharmgate/Jinhe franchise in the Americas."

About Pharmgate LLC
Pharmgate LLC is the majority-owned US subsidiary of Jinhe Biotechnology Co., Ltd., P. R. China, the world leader in the production of chlortetracycline feed grade, chlortetracycline hydrochloride, salinomycin and other animal health compounds. The company has marketing or supply approvals for these products in most major markets throughout the world.

BLUE BIRD LABELS

View Labels »

GLOBAL VET LINK

Visit Website »

NEWS

  • October 12, 2016 Pharmgate concludes merger with ProtaTek International, Inc.

    September 15, 2016 Pharmgate announces agreement to acquire ProtaTek International, Inc.

    January 6, 2016 - Pharmgate Joins GVL® FeedLINK® Electronic VFD System

    August 1, 2016 - Pharmgate announces new appointments.

    January 6, 2016 - Pharmgate Joins GVL® FeedLINK® Electronic VFD System

  • November 25, 2013 - Pharmgate receives regulatory approval for its chlortetracycline product, Deracin® 22% Granular, in Canada.

    August 13, 2015 - Pharmgate is pleased to announce the relocation of its headquarters from Ramsey, New Jersey to Wilmington, North Carolina.

  • March 17, 2014 - Pharmgate Animal Health announces the Canadian launch of Aivlosin® 17% Tylvalosin Medicated Premix for the treatment of porcine proliferative enteritis (PPE) associated with Lawsonia intracellularis infection in swine

    August 8, 2013 - Pharmgate acquires chlortetracycline product licenses in Latin America.

  • August 1, 2014 - ECO Animal Health and its North American marketing joint venture, Pharmgate Animal Health, announce...

    August 1, 2014 - Pharmgate Animal Health announces two Sales and Marketing appointments.

  • November 3, 2014 - Pharmgate concludes acquisition of Pennfield Animal Health

    October 16, 2014 - Pharmgate announces agreement to acquire the assets of Pennfield Animal Health.

CONTACT US

Pharmgate Animal Health LLC
1015 Ashes Drive, Suite 102
Wilmington, NC 28405
Tel: 1-800-380-6099
Fax: 910-679-8368

Pharmgate Animal Health Canada, Inc.
5204 Tenth Line, R.R. #2
Erin, Ontario N0B 1T0
Tel: 1-800-465-2450
Fax: 910-679-8368